FDA Accelerates Clinical Trials with Real-Time Data, Pfizer Extends Vyndamax Patent Until 2031
The FDA is piloting real-time clinical trial data reviews with AstraZeneca and Amgen, while Pfizer settles patent disputes to extend Vyndamax protecti...
The FDA is piloting real-time clinical trial data reviews with AstraZeneca and Amgen, while Pfizer settles patent disputes to extend Vyndamax protecti...
The FDA has announced a new effort to enhance clinical trial efficiency by reviewing real-time data from trials conducted by AstraZeneca and Amgen. Th...